Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 10/20 | 0.45 |
| ▸ | JAK2 | O60674 | 6/20 | 0.45 |
| ▸ | TYK2 | P29597 | 4/20 | 0.45 |
| ▸ | JAK3 | P52333 | 2/20 | 0.45 |
| ▸ | SFRP1 | Q8N474 | 3/20 | 0.40 |
| ▸ | STS | P08842 | 2/20 | 0.39 |
| ▸ | BTK | Q06187 | 2/20 | 0.38 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.37 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2281009 | 0.83 | JAK1 (0.43) | JAK1JAK2TYK2JAK3SFRP1 | |
| SCHEMBL2276488 | 0.82 | JAK1 (0.46) | JAK1JAK2TYK2JAK3SFRP1 | |
| SCHEMBL2274401 | 0.81 | JAK1 (0.46) | JAK1JAK2TYK2JAK3SFRP1 | |
| SCHEMBL2277601 | 0.80 | JAK1 (0.45) | JAK1JAK2TYK2JAK3SFRP1 | |
| SCHEMBL2276588 | 0.80 | JAK1 (0.45) | JAK1JAK2TYK2JAK3SFRP1 | |
| SCHEMBL2278106 | 0.80 | JAK1 (0.45) | JAK1JAK2TYK2JAK3SFRP1 | |
| SCHEMBL2284404 | 0.80 | JAK1 (0.48) | JAK1JAK2TYK2JAK3BTK | |
| SCHEMBL2278902 | 0.80 | JAK1 (0.44) | JAK1JAK2TYK2JAK3SFRP1 | |
| SCHEMBL2284925 | 0.80 | JAK1 (0.44) | JAK1JAK2TYK2JAK3STS | |
| SCHEMBL2277282 | 0.80 | JAK1 (0.44) | JAK1JAK2TYK2JAK3SFRP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |